Ryyan Alobaidi

4PUBLICATIONS
10CO-AUTHORS
Radiation and matterMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 15, 2026
Correction: Simbulan-Rosenthal et al. Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. Int. J. Mol. Sci. 2022, 23, 2333.

|Apr 27, 2026
Correction: Alobaidi et al. Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma Stem Cell Apoptosis and Blocks NRAS Tumor Growth. Cells 2025, 14, 248.

|Nov 13, 2025
Correction: Simbulan-Rosenthal et al. CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis. Cancers 2019, 11, 1490.

Cynthia M Simbulan-Rosenthal, Ryan Dougherty, Sahar Vakili

|Feb 25, 2025
Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma Stem Cell Apoptosis and Blocks NRAS Tumor Growth.

Ryyan Alobaidi, Nusrat Islam, Toni Olkey

Pageof 1

Frequent Collaborators

4 joint publications

Peter Sykora

4 joint publications

Cynthia M Simbulan-Rosenthal

4 joint publications

Dean S Rosenthal

3 joint publications

Yogameenakshi Haribabu